Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,559 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Arizona Cognitive Test Battery for Down Syndrome: Test-Retest Reliability and Practice Effects.
Edgin JO, Anand P, Rosser T, Pierpont EI, Figueroa C, Hamilton D, Huddleston L, Mason G, Spanò G, Toole L, Nguyen-Driver M, Capone G, Abbeduto L, Maslen C, Reeves RH, Sherman S. Edgin JO, et al. Among authors: hamilton d. Am J Intellect Dev Disabil. 2017 May;122(3):215-234. doi: 10.1352/1944-7558-122.3.215. Am J Intellect Dev Disabil. 2017. PMID: 28452581 Free PMC article.
Associations Between Medical History, Cognition, and Behavior in Youth With Down Syndrome: A Report From the Down Syndrome Cognition Project.
Rosser TC, Edgin JO, Capone GT, Hamilton DR, Allen EG, Dooley KJ, Anand P, Strang JF, Armour AC, Frank-Crawford MA, Channell MM, Pierpont EI, Feingold E, Maslen CL, Reeves RH, Sherman SL. Rosser TC, et al. Am J Intellect Dev Disabil. 2018 Nov;123(6):514-528. doi: 10.1352/1944-7558-123.6.514. Am J Intellect Dev Disabil. 2018. PMID: 30421968 Free PMC article.
Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validity.
Abbeduto L, Berry-Kravis E, Sterling A, Sherman S, Edgin JO, McDuffie A, Hoffmann A, Hamilton D, Nelson M, Aschkenasy J, Thurman AJ. Abbeduto L, et al. Among authors: hamilton d. J Neurodev Disord. 2020 Mar 24;12(1):10. doi: 10.1186/s11689-020-09313-6. J Neurodev Disord. 2020. PMID: 32204695 Free PMC article.
Correction to: Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validity.
Abbeduto L, Berry-Kravis E, Sterling A, Sherman S, Edgin JO, McDuffie A, Hoffmann A, Hamilton D, Nelson M, Aschkenasy J, Thurman AJ. Abbeduto L, et al. Among authors: hamilton d. J Neurodev Disord. 2020 Apr 2;12(1):11. doi: 10.1186/s11689-020-09314-5. J Neurodev Disord. 2020. PMID: 32241250 Free PMC article.
Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language sampling.
Thurman AJ, Edgin JO, Sherman SL, Sterling A, McDuffie A, Berry-Kravis E, Hamilton D, Abbeduto L. Thurman AJ, et al. Among authors: hamilton d. J Neurodev Disord. 2021 Apr 8;13(1):13. doi: 10.1186/s11689-021-09361-6. J Neurodev Disord. 2021. PMID: 33827417 Free PMC article.
2,559 results